Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The European Research Initiative on Chronic Lymphocytic Leukemia (ERIC) International Meeting 2018, the first of its kind, was held in Barcelona, Spain, from 25–27 October. Explore the latest CLL news with meeting highlights from the speakers themselves, including biomarkers, opinion on MRD, epigenetics and data to watch out for at ASH 2018.

ERIC 2018

25–27 October 2018 | Barcelona, Spain

ERIC 2018

25–27 October 2018 | Barcelona, Spain
The European Research Initiative on Chronic Lymphocytic Leukemia (ERIC) International Meeting 2018, the first of its kind, was held in Barcelona, Spain, from 25–27 October. Explore the latest CLL news with meeting highlights from the speakers themselves, including biomarkers, opinion on MRD, epigenetics and data to watch out for at ASH 2018.
Projections from real world evidence of CLL management 4:20
Projections from real world evidence of CLL management
Robin Foà • 25 Oct 2018
Treatment-changing advancements in CLL: BTK, BCL-2, CD20 & CAR T-cells 9:35
Treatment-changing advancements in CLL: BTK, BCL-2, CD20 & CAR T-cells
Kanti Rai • 25 Oct 2018
Current ERIC research in the CLL genomics field 1:50
Current ERIC research in the CLL genomics field
Richard Rosenquist • 25 Oct 2018
ERIC’s first International Meeting and plans for the future 1:52
ERIC’s first International Meeting and plans for the future
Paolo Ghia • 25 Oct 2017
Resistance mechanisms in CLL 3:08
Resistance mechanisms in CLL
Richard Rosenquist • 25 Oct 2018
Opinion on MRD in CLL: routine use or clinical trials? 3:18
Opinion on MRD in CLL: routine use or clinical trials?
Kanti Rai • 25 Oct 2018
Genomic discoveries in CLL 2:49
Genomic discoveries in CLL
Richard Rosenquist • 25 Oct 2018
Current knowledge of the TP53 mutation and its role in CLL 2:36
Current knowledge of the TP53 mutation and its role in CLL
Jitka Malčíková • 25 Oct 2018
Prognostic markers and MRD in CLL 6:28
Prognostic markers and MRD in CLL
Robin Foà • 25 Oct 2018
Progress in CLL diagnosis and treatment 1:37
Progress in CLL diagnosis and treatment
Kanti Rai • 25 Oct 2018
European Research Initiative on CLL (ERIC) International Meetings 1:00
European Research Initiative on CLL (ERIC) International Meetings
Kostas Stamatopoulos • 25 Oct 2018
CLL cell dynamics 2:13
CLL cell dynamics
Nicholas Chiorazzi • 25 Oct 2018
An update on ERIC initiatives 0:51
An update on ERIC initiatives
Paolo Ghia • 25 Oct 2018
CLL treatment duration and the role of MRD 1:44
CLL treatment duration and the role of MRD
Peter Hillmen • 25 Oct 2018
The future of CLL: managing new toxicities and improved categorization 1:49
The future of CLL: managing new toxicities and improved categorization
Daniel Catovsky • 25 Oct 2018
Cell-intrinsic biomarkers in CLL: focus on cytogenetics 3:01
Cell-intrinsic biomarkers in CLL: focus on cytogenetics
Blanca Espinet • 25 Oct 2018

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals